Covered recipient · General Payments record
SHARON A BUTCHER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,800.96
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $302.03 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $104.90 | 5 |
| Organon LLC | $55.90 | 2 |
| Pacira Pharmaceuticals Incorporated | $41.86 | 2 |
| SHIELD THERAPEUTICS INC | $29.24 | 2 |
| Seqirus USA Inc | $23.77 | 1 |
| PFIZER INC. | $16.82 | 1 |
| Novo Nordisk AS | $15.18 | 1 |
| Exeltis, USA Inc. | $14.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $18.58 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404902 | CMS |
| Daiichi Sankyo Inc. | $18.53 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404906 | CMS |
| Daiichi Sankyo Inc. | $24.44 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404904 | CMS |
| Daiichi Sankyo Inc. | $23.26 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404908 | CMS |
| Daiichi Sankyo Inc. | $20.09 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404900 | CMS |
| Exeltis, USA Inc. | $14.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149989323 | CMS |
| Novo Nordisk Inc | $15.18 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097018943 | CMS |
| Organon Llc | $26.74 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136226855 | CMS |
| Organon Llc | $29.16 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136226851 | CMS |
| Pacira Pharmaceuticals Incorporated | $20.85 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151258914 | CMS |
| Pacira Pharmaceuticals Incorporated | $21.01 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151258916 | CMS |
| PFIZER INC. | $16.82 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131685380 | CMS |
| Seqirus USA Inc | $23.77 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125630964 | CMS |
| SHIELD THERAPEUTICS INC | $15.13 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150136769 | CMS |
| SHIELD THERAPEUTICS INC | $14.11 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150144758 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.